The FDA clears AppliedVR headset to help treat fibromyalgia and chronic pain

Conclusions: High engagement and satisfaction combined with low levels of adverse effects support the feasibility and acceptability of at-home skills-based VR for chronic pain. A significant reduction in pain outcomes over the course of the 21-day treatment both within the VR group and compared with an audio-only version suggests that VR has the potential to provide enhanced treatment and greater improvement across a range of pain outcomes. These findings provide a foundation for future research on VR behavioral interventions for chronic pain. News in Context: FDA clears MindMaze GO neurorehabilitation platform, easing access to continued outpatient therapy Virtual-reality gaming + affordable biofeedback = Anxiety therapy for all? Study: Self-driving cars will increase motion sickness…unless we retrain our brains to improve visuospatial skills Washington Wizards to test virtual reality system to better monitor players’ fatigue ? How to intervene early: Examples in depression, epilepsy and smoking cessation from SharpBrainsThe post The FDA clears AppliedVR headset to help treat fibromyalgia and chronic pain first appeared on SharpBrains.
Source: SharpBrains - Category: Neuroscience Authors: Tags: Brain/ Mental Health Technology & Innovation AppliedVR back pain Breakthrough Device Designation chronic pain EaseVRx FDA fibromyalgia virtual-reality Source Type: blogs